Patents-Review.com
ClassID:

110832 ⎘

C12N2760/16223 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus B, i.e. influenza B virus Virus like particles [VLP]

Recent Application in this class:
#1
20260000747
2026-01-01

INFLUENZA VIRUS VACCINES AND USES THEREOF

 #2
20250288662
2025-09-18

MULTIVALENT DISPLAY ON ENVELOPED PARTICLES WITH HUMAN OLIGOMERIZATION DOMAINS

 #3
20240226267
2024-07-11

INFLUENZA VACCINE COMPOSITIONS AND METHODS OF USING SAME

 #4
20240131145
2024-04-25

INFLUENZA VACCINE COMPOSITIONS AND METHODS OF USING SAME

 #5
20220242918
2022-08-04

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

 #6
20220145317
2022-05-12

INFLUENZA VIRUS-LIKE PARTICLE PRODUCTION IN PLANTS

 #7
20220127582
2022-04-28

Proliferation method

 #8
20200263142
2020-08-20

Generation of infectious influenza viruses from virus-like particles

 #9
20200255849
2020-08-13

Influenza virus-like particle production in plants

 #10
20200247852
2020-08-06

Headless hemagglutin influenza vaccine

 #11
20200223892
2020-07-16

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

 #12
20190177739
2019-06-13

Recombinant influenza virus-like particles (VLPS) produced in transgenic plants

 #13
20190099484
2019-04-04

Influenza virus vaccines and uses thereof

 #14
20190062713
2019-02-28

Highly efficient influenza matrix (M1) proteins

 #15
20190008949
2019-01-10

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR INFLUENZA

 #16
20180333479
2018-11-22

INFLUENZA VIRUS VACCINES AND USES THEREOF

 #17
20180298063
2018-10-18

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

 #18
20180133303
2018-05-17

Virus-like particles

 #19
20170253861
2017-09-07

Highly efficient influenza matrix (M1) proteins

 #20
20170196965
2017-07-13

Vaccine containing virus-like particles

 #21
20170128562
2017-05-11

Polyvalent influenza virus-like particles (VLPS) and use as vaccines

 #22
20170088848
2017-03-30

Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin

 #23
20170058265
2017-03-02

Generation of infectious influenza viruses from virus-like particles

 #24
20160361408
2016-12-15

Influenza virus vaccines and uses thereof

 #25
20160122777
2016-05-05

Influenza virus-like particle production in plants

 #26
20150335729
2015-11-26

Influenza virus vaccines and uses thereof

 #27
20150307849
2015-10-29

Highly efficient influenza matrix (M1) proteins

 #28
20150104480
2015-04-16

Increasing virus-like particle yield in plants

 #29
20150044247
2015-02-12

Computationally optimized broadly reactive antigens for H3N2, H2N2, and B influenza viruses

 #30
20140328875
2014-11-06

Influenza virus vaccines and uses thereof

 #31
20130183342
2013-07-18

Computationally optimized broadly reactive antigens for influenza

 #32
20130142826
2013-06-06

Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin

 #33
20130039938
2013-02-14

Highly efficient influenza matrix (M1) proteins

 #34
20120189658
2012-07-26

Chimeric influenza virus-like particles comprising hemagglutinin

 #35
20110191915
2011-08-04

Influenza virus immunizing epitope

 #36
20110142863
2011-06-16

FLOW THROUGH PURIFICATION PROCESSES FOR LARGE BIOMOLECULES

 #37
20110008838
2011-01-13

CHIMERIC VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES

 #38
20100310604
2010-12-09

RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ

 #39
20100184192
2010-07-22

Avian influenza chimeric VLPS

 #40
20090022762
2009-01-22

Polyvalent influenza virus-like particle (VLP) compositions

 #41
20070225227
2007-09-27

Lipoparticles comprising ion channels, methods of making and using the same